Natural history of amyotrophic lateral sclerosis in a database population validation of a scoring system and a model for survival prediction

Brain

Volumn 118, Issue 3, 1995, Pages 707-719

  Haverkamp, Lanny J ^a   Appel, Vicki ^a   Appel, Stanley H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Historical control; Scoring system; Survival prediction

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; DATA BASE; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PREDICTION; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SCORING SYSTEM; SURVIVAL TIME;

ADULT; AGE FACTORS; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BIOPSY; CLINICAL TRIALS; COMORBIDITY; DATABASES, FACTUAL; DISEASE PROGRESSION; ELECTROMYOGRAPHY; FEMALE; GASTROSTOMY; HUMAN; LIFE TABLES; MALE; MIDDLE AGE; MUSCLE, SKELETAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RESPIRATION, ARTIFICIAL; RESPIRATORY PARALYSIS; SEVERITY OF ILLNESS INDEX; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS; TEXAS;

EID: 0029037348     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/118.3.707     Document Type: Article

References (31)

1. Adams PF. Current estimates from the national health interview survey, 1990. Vital and health statistics. Series 10: data from the national health survey. No. 181. Hyatsville (MD): US Department of Health and Human Services, 1991
2. Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 1986; 36: 937-41
3. Annegers JF, Appel S, Lee JR, Perkins P., Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas. 1985-1988. Arch Neurol 1991; 48: 589-93
4. Appel SH, Stockton-Appel V, Stewart SS, Kerman RH. Amyotrophic lateral sclerosis: associated clinical disorders and immunological evaluations. Arch Neurol 1986; 43: 234-8
5. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987; 22: 328-33
6. Bharucha NE, Schoenberg BS, Raven RH, Pickle LW, Byar DP, Mason TJ. Geographic distribution of motor neuron disease and correlation with possible étiologie factors. Neurology 1983; 33: 911-15
7. Bowling AC, Schulz JB, Brown RH Jr., Beal MF. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993; 61: 2322-5
8. Caroscio JT. Mulvihill MN, Sterling R, Abrams B. Amyotrophic lateral sclerosis. Its natural history. Neurol Clin 1987; 5: 1-8
9. Cox DR. Regression models and life-tables. J R Stat Soc B 1972; 34: 187-202
10. Eisen A, Schulzer M, MacNeil M, Pant B, Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve 1993; 16: 27-32
11. Gubbay SS, Kahana E, Zilber N, Cooper G, Pintov S, Leibowitz Y. Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol 1985; 232: 295-300
12. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J 1958; 53: 457-81
14. Kew JJM, Goldstein LH, Leigh PN, Abrahams S, Cosgrave N, Passingham RE, et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study. Brain 1993; 116: 1399-423
15. 2+ channel alpha I subunit [see comments], Ann Neurol 1994; 35: 164-71. Comment in: Ann Neurol 1994; 35: 131-2
16. Kurtzke JF, Kurland LT. The epidemiology of neurologic disease. In: Joynt RJ, editor. Clinical neurology, Vol. 4, Chap. 66. Philadelphia: J.B. Lippincott, 1983: 1-43
17. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38: 963-74
18. Ludolph AC, Langen KJ, Regard M, Herzog H, Kemper B, Kuwert T, et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand 1992; 85: 81-9
19. Munsat TL, Andres PL, Finison L, Conlon T, Thibodeau L. The natural history of motoneuron loss in amyotrophic lateral sclerosis. Neurology 1988; 38: 409-13
20. Norris FH Jr, Calanchini PR, Fallat RJ, Panchari S, Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974; 24: 721-8
21. Norris F, Shepherd R, Denys E, Kwei U, Mukai E, Elias L, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sei 1993; 118: 48-55
22. Olarte MR. Therapeutic trials in amyotrophic lateral sclerosis. Adv Neurol 1982; 36: 555-7
23. Pestronk A, Adams RN, Clawson L, Comblath D, Kuncl RW, Griffin D, et al. Serum antibodies to GM ganglioside in amyotrophic lateral sclerosis. Neurology 1988; 38: 1457-61
24. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39
25. Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, Miller RG, et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993; 43: 1316-22
26. Rosen AD. Amyotrophic lateral sclerosis. Clinical features and prognosis. Arch Neurol 1978; 35: 638-42
27. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hantati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis [published erratum appears in Nature 1993; 364: 362] [see comments]. Nature, 1993; 362: 59-62. Comment in: Nature 1993; 362: 20-1
28. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis [see comments], N Engl J Med 1992; 326: 1464-8. Comment in: N Engl J Med 1992; 326: 1493-5
29. Smith RG, Hamilton S, Hofmann F, Schneider T, Nastainczyk W, Bimbaumer L, et al. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis [see comments]. N Engl J Med 1992; 327: 1721-8. Comment in: N Engl J Med 1992; 327: 1752-3, Comment in: N Engl J Med 1993; 328: 1355-6; discussion 1356-7, Comment in: N Engl J Med 1993: 328: 1356; discussion 1356-7
30. Tibshirani R. A plain man’s guide to the proportional hazards model. Clin Invest Med 1982; 5: 63-8
31. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs (NJ): Prentice-Hall, 1984